Literature DB >> 15155300

Intrathecal midazolam II: combination with intrathecal fentanyl for labor pain.

Adam P Tucker1, Joseph Mezzatesta, Raymond Nadeson, Colin S Goodchild.   

Abstract

UNLABELLED: Recent investigations have sought to improve intrathecal analgesia by combining opioids with other classes of analgesics. In this study we assessed the ability of intrathecal midazolam to increase the potency and duration of the analgesic effects of intrathecal fentanyl without causing adverse effects. Thirty parturients with cervical dilations 2-6 cm were randomized to receive either intrathecal midazolam 2 mg, fentanyl 10 micro g, or both combined to initiate analgesia. Pain scores were recorded before and at 5-min intervals for 30 min after the injection and then every 30 minutes until the patient requested further analgesia. The presence and severity of nausea, emesis, pruritus, headache, and sedation, in addition to arterial blood pressure, heart rate, respiratory rate, sensory changes to ice, motor impairment, cardiotocograph, and Apgar score were also recorded. The parturients were assessed after 2 days and 1 mo for neurologic impairment. Preinjection pain scores were unaltered by intrathecal midazolam alone and moderately decreased by fentanyl. Intrathecal midazolam increased the analgesic effect of fentanyl. No treatment altered cardiorespiratory variables or caused motor impairment. The addition of intrathecal midazolam to fentanyl did not increase the occurrence of any maternal adverse event or abnormalities on the cardiotocograph. We conclude that intrathecal midazolam enhanced the analgesic effect of fentanyl without increasing maternal or fetal adverse effects. IMPLICATIONS: Treatment of labor pain with epidural injections of local anesthetic is complicated by decreases in arterial blood pressure and leg weakness. This study showed that a mixture of two drugs, fentanyl and midazolam, could provide powerful pain relief when the drugs were given together spinally without such side effects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15155300     DOI: 10.1213/01.ane.0000112434.68702.e4

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  24 in total

Review 1.  Risks versus benefits of gastrointestinal endoscopy during pregnancy.

Authors:  Mitchell S Cappell
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-10-04       Impact factor: 46.802

2.  Antiemetic effects of midazolam added to fentanyl-ropivacaine patient-controlled epidural analgesia after subtotal gastrectomy: A prospective, randomized, double-blind, controlled trial.

Authors:  Sioh Kim; Jeongwon Seo; Younghoon Jeon
Journal:  Curr Ther Res Clin Exp       Date:  2010-10

3.  Pharmacological and antihyperalgesic properties of the novel α2/3 preferring GABAA receptor ligand MP-III-024.

Authors:  Bradford D Fischer; Raymond J Schlitt; Bryan Z Hamade; Sabah Rehman; Margot Ernst; Michael M Poe; Guanguan Li; Revathi Kodali; Leggy A Arnold; James M Cook
Journal:  Brain Res Bull       Date:  2017-03-04       Impact factor: 4.077

4.  Labour pains.

Authors:  Michael Andrew Duncan
Journal:  Can Fam Physician       Date:  2008-01       Impact factor: 3.275

5.  Antinociceptive Effects of a Novel α2/α3-Subtype Selective GABAA Receptor Positive Allosteric Modulator.

Authors:  Lakeisha A Lewter; Janet L Fisher; Justin N Siemian; Kashi Reddy Methuku; Michael M Poe; James M Cook; Jun-Xu Li
Journal:  ACS Chem Neurosci       Date:  2017-02-13       Impact factor: 4.418

Review 6.  Neuraxial drug administration: a review of treatment options for anaesthesia and analgesia.

Authors:  Stephan A Schug; David Saunders; Irina Kurowski; Michael J Paech
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

7.  A randomised controlled trial comparing the effect of adjuvant intrathecal 2 mg midazolam to 20 micrograms fentanyl on postoperative pain for patients undergoing lower limb orthopaedic surgery under spinal anaesthesia.

Authors:  Francis Codero; Mung'ayi Vitalis; Sharif Thikra
Journal:  Afr Health Sci       Date:  2016-03       Impact factor: 0.927

Review 8.  Current and Future Issues in the Development of Spinal Agents for the Management of Pain.

Authors:  Tony L Yaksh; Casey J Fisher; Tyler M Hockman; Ashley J Wiese
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

Review 9.  Basic/Translational Development of Forthcoming Opioid- and Nonopioid-Targeted Pain Therapeutics.

Authors:  Nebojsa Nick Knezevic; Ajay Yekkirala; Tony L Yaksh
Journal:  Anesth Analg       Date:  2017-11       Impact factor: 5.108

Review 10.  Flupirtine, a re-discovered drug, revisited.

Authors:  Istvan Szelenyi
Journal:  Inflamm Res       Date:  2013-01-16       Impact factor: 4.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.